Abstract
Purpose
Polycystic ovary syndrome (PCOS) is the most common endocrine-reproductive disease linked not just to infertility but also to serious comorbidities. There is a reported association between low vitamin D levels and multiple health conditions including PCOS. This narrative review aims to analyze the role of vitamin D in PCOS development, use of the vitamin D in the treatment of PCOS, and the molecular basis of these observations.
Methods
A Medline and PubMed research was performed, during the years 1990–2023, using a combination of keywords on such topic. According to the author's evaluation and target, papers were identified and included for a narrative review.
Results
There are associations between lower levels of vitamin D and PCOS, as well as with insulin resistance, metabolic syndrome, hyperandrogenemia, metabolic and endocrine disorders as well as the onset of oxidative stress and pro-inflammatory milieu, in PCOS women.
Conclusion
Vitamin D has a role in pathologic changes linked to PCOS. Molecular and clinical investigations which give new information about the role of vitamin D in the development of PCOS and related endocrine and metabolic disturbance are further needed.
Similar content being viewed by others
Data availability
It is not feasible for a review, as all the data belong to papers already published and included in the review.
References
Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M (2022) Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci 23:583. https://doi.org/10.3390/ijms23020583
Polycystic Ovary Syndrome. Accessed on 20. Mart 2023. https://www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome
Patel S (2018) Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol 182:27–36. https://doi.org/10.1016/j.jsbmb.2018.04.008
Azziz R (2018) Polycystic ovary syndrome. Obstet Gynecol 132:321–336. https://doi.org/10.1097/AOG.0000000000002698
Patten RK, McIlvenna LC, Moreno-Asso A, Hiam D, Stepto NK, Rosenbaum S, Parker AG (2023) Efficacy of high-intensity interval training for improving mental health and health-related quality of life in women with polycystic ovary syndrome. Sci Rep 1:3025. https://doi.org/10.1038/s41598-023-29503-1
Bednarska S, Siejka A (2017) The pathogenesis and treatment of polycystic ovary syndrome: What’s new? Adv Clin Exp Med 26:359–367. https://doi.org/10.17219/acem/59380
Peng G, Yan Z, Liu Y, Li J, Ma J, Tong N, Wang Y (2023) The effects of first-line pharmacological treatments for reproductive outcomes in infertile women with PCOS: a systematic review and network meta-analysis. Reprod Biol Endocrinol 21:24. https://doi.org/10.1186/s12958-023-01075-9
Michael W, Couture AD, Swedlund M, Hampton A, Eglash A, Schrager S (2022) An evidence-based review of vitamin d for common and high-mortality conditions. J Am Board Fam Med 35:1217–1229. https://doi.org/10.3122/jabfm.2022.220115R1
Bouillon R, Manousaki D, Rosen C, Trajanoska K, Rivadeneira F, Richards JB (2022) The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol 18:96–110. https://doi.org/10.1038/s41574-021-00593-z
Franasiak JM, Lara EE, Pellicer A (2017) Vitamin D in human reproduction. Curr Opin Obstet Gynecol 29:189–194. https://doi.org/10.1097/GCO.0000000000000375
Grundmann M, von Versen-Höynck F (2011) Vitamin D - roles in women’s reproductive health? Reprod Biol Endocrinol 9:146. https://doi.org/10.1186/1477-7827-9-146
Fichera M, Török P, Tesarik J, Della Corte L, Rizzo G, Garzon S, Carlea A, Di Angelo Antonio S, Zito G, Panella MM (2020) Vitamin D, reproductive disorders and assisted reproduction: evidences and perspectives. Int J Food Sci Nutr 71: 276–285: https://doi.org/10.1080/09637486.2019.1661978.
Malm G, Lindh CH, Hansson SR, Källén K, Malm J, Rylander L (2023) Maternal serum vitamin D level in early pregnancy and risk for preeclampsia: A case-control study in Southern Sweden. PLoS ONE 18:e0281234. https://doi.org/10.1371/journal.pone.0281234
Hasan HA, Barber TM, Cheaib S, Coussa A (2023) Preconception vitamin d level and in vitro fertilization: pregnancy outcome. Endocr Pract 12: S1530–891X(23)00016–2. https://doi.org/10.1016/j.eprac.2023.01.005.
Bindayel IA (2021) Low vitamin D level in saudi women with polycystic ovary syndrome. Front Nutr 8:611351. https://doi.org/10.3389/fnut.2021.611351
Ozyurt R, Karakus C (2022) Follicular fluid 25-hydroxyvitamin D levels determine fertility outcome in patients with polycystic ovary syndrome. Taiwan J Obstet Gynecol 61: 620–625: https://doi.org/10.1016/j.tjog.2022.03.041.
Dokuzeylül Güngör N, Güngör K, Celik N, Önal M, Madenli AA (2023) Impact of body mass index and vitamin D on serum AMH levels and antral follicle count in PCOS. Eur Rev Med Pharmacol Sci 27:179–187. https://doi.org/10.26355/eurrev_202301_30870
Gokosmanoglu F, Onmez A, Ergenç H (2020) The relationship between Vitamin D deficiency and polycystic ovary syndrome. Afr Health Sci 20:1880–1886. https://doi.org/10.4314/ahs.v20i4.45
Dawood AS, Elgergawy A, Elhalwagy A (2018) Circulating levels of vitamin d3 and leptin in lean infertile women with polycystic ovary syndrome. J Hum Reprod Sci 11:343–347. https://doi.org/10.4103/jhrs.JHRS_40_18
Simpson S, Seifer DB, Shabanova V, Lynn AY, Howe C, Rowe E, Caprio S, Vash-Margita A (2020) The association between anti-Müllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females. Reprod Biol Endocrinol 18:118. https://doi.org/10.1186/s12958-020-00676-y
Bostanci EI, Ozler S, Yilmaz NK, Yesilyurt H (2018) Serum 25-hydroxy vitamin d levels in turkish adolescent girls with polycystic ovary syndrome and the correlation with clinical/biochemical parameters. J Pediatr Adolesc Gynecol 31:270–273. https://doi.org/10.1016/j.jpag.2017.07.008
Arslan E, Gorkem U, Togrul C (2019) Is there a relationship between vitamin d deficiency status and PCOS in infertile women? GeburtshilfeFrauenheilkd 79:723–730. https://doi.org/10.1055/a-0871-6831
Nandi ER, Fatima P, Deeba F, Ara R, Dey S, Islam F (2023) Association between serum vitamin d and metabolic syndrome in women with polycystic ovary syndrome. Mymensingh Med J 32:125–134
Krul-Poel YHM, Koenders PP, Steegers-Theunissen RP, Ten Boekel, E, Wee, MMT, Louwers, Y, Lips, P, Laven, JSE, Simsek, S (2018) Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): a cross-sectional study. PLoS ONE 13: e0204748: https://doi.org/10.1371/journal.pone.020474
Wang L, Lv S, Li F, Yu X, Bai E, Yang X (2020) Vitamin D deficiency is associated with metabolic risk factors in women with polycystic ovary syndrome: a cross-sectional study in Shaanxi China. Front Endocrinol (Lausanne) 11:171. https://doi.org/10.3389/fendo.2020.00171
He C, Lin Z, Robb SW, Ezeamama AE (2015) Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients 7:4555–4577. https://doi.org/10.3390/nu7064555
Łagowska K, Bajerska J, Jamka M (2018) The role of vitamin D Oral supplementation in insulin resistance in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Nutrients 10:1637. https://doi.org/10.3390/nu10111637
Fang F, Ni K, Cai Y, Shang J, Zhang X, Xiong C (2017) Effect of vitamin D supplementation on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract 26:53–60. https://doi.org/10.1016/j.ctcp.2016.11.008
Azadi-Yazdi M, Nadjarzadeh A, Khosravi-Boroujeni H, Salehi-Abargouei A (2017) The effect of vitamin d supplementation on the androgenic profile in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials. Horm Metab Res 49:174–179. https://doi.org/10.1055/s-0043-103573
Jia XZ, Wang YM, Zhang N, Guo LN, Zhen XL, Li H et al (2015) Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: a meta-analysis. J Obstet Gynaecol Res 41:1791–1802. https://doi.org/10.1111/jog.12793
Pergialiotis V, Karampetsou N, Panagopoulos P, Trakakis E, Papantoniou N (2017) The effect of Vitamin D supplementation on hormonal and glycaemic profile of patients with PCOS: a meta-analysis of randomised trials. Int J Clin Pract. https://doi.org/10.1111/ijcp.12957
Santos BR, Lecke SB, Spritzer PM (2018) Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study. Reprod Biol Endocrinol 16:38. https://doi.org/10.1186/s12958-018-0355-9
Xavier LB, Gontijo NA, Rodrigues KF, Cândido AL, Dos Reis FM, de Sousa MCR, Silveira JN, Oliveira Silva IF, Ferreira, CN, Gomes, KB (2019) Polymorphisms in vitamin D receptor gene, but not vitamin D levels, are associated with polycystic ovary syndrome in Brazilian women. Gynecol Endocrinol 35:146–149: https://doi.org/10.1080/09513590.2018.1512966.
Shahmoradi A, Aghaei A, Ghaderi K, Jafar Rezaei M, Azarnezhad A (2022) A meta-analysis of the association of ApaI, BsmI, FokI, and TaqI polymorphisms in the vitamin D receptor gene with the risk of polycystic ovary syndrome in the Eastern Mediterranean Regional Office population. Int J Reprod Biomed 20: 433–446: https://doi.org/10.18502/ijrm.v20i6.11439.
Shi XY, Huang AP, Xie DW, Yu XL (2019) Association of vitamin D receptor gene variants with polycystic ovary syndrome: a meta-analysis. BMC Med Genet 20:32. https://doi.org/10.1186/s12881-019-0763-5
Liang F, Ren N, Zhang H, Zhang J, Wu Q, Song R, Shi Z, Zhang Z, Wang K (2019) A meta-analysis of the relationship between vitamin D receptor gene ApaI polymorphisms and polycystic ovary syndrome. Adv Clin Exp Med 28:255–262. https://doi.org/10.17219/acem/85882
Niu YM, Wang YD, Jiang GB, Bai G, Chai HB, Li XF, Hu YY, Shen M (2019) Association Between Vitamin D Receptor Gene Polymorphisms and Polycystic Ovary Syndrome Risk: A Meta-Analysis. Front Physiol 9: 1902: doi: https://doi.org/10.3389/fphys.2018.01902.
Várbíró S, Takács I, Tűű L, Nas K, Sziva RE, Hetthéssy JR et al (2022) Effects of Vitamin D on Fertility, Pregnancy and Polycystic Ovary Syndrome-A Review. Nutrients 14:1649. https://doi.org/10.3390/nu14081649
Butts SF, Seifer DB, Koelper N, Senapati S, Sammel MD, Hoofnagle AN et al (2019) Vitamin D Deficiency Is Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility. J Clin Endocrinol Metab 104:369–378. https://doi.org/10.1210/jc.2018-00750
Dastorani M, Aghadavod E, Mirhosseini N, Foroozanfard F, Zadeh Modarres S, Amiri Siavashani M, Asemi Z (2018) The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod Biol Endocrinol 16:94. https://doi.org/10.1186/s12958-018-0413-3
Maktabi M, Chamani M, Asemi Z (2017) The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. HormMetab Res 49:493–498. https://doi.org/10.1055/s-0043-107242
Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T (2019) A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients 11:188. https://doi.org/10.3390/nu11010188
Trummer C, Schwetz V, Kollmann M, Wölfler M, Münzker J, Pieber TR, Pilz S, Heijboer AC, Obermayer-Pietsch B, Lerchbaum E (2019) Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial. Eur J Nutr 58:2019–2028. https://doi.org/10.1007/s00394-018-1760-8
Figurová J, Dravecká I, Petríková J, Javorský M, Lazúrová I (2017) The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome. Horm Mol Biol Clin Investig 29:85–91. https://doi.org/10.1515/hmbci-2016-0039
Razavi M, Jamilian M, Karamali M, Bahmani F, Aghadavod E, Asemi Z (2016) The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Horm Metab Res 48:446–451. https://doi.org/10.1055/s-0042-104060
Miao CY, Fang XJ, Chen Y, Zhang Q (2020) Effect of vitamin D supplementation on polycystic ovary syndrome: A meta-analysis. Exp Ther Med 19:2641–2649. https://doi.org/10.3892/etm.2020.8525
Wang Q, Sun Y, Xu Q, Liu W, Wang P, Yao J et al (2022) Higher dietary inflammation potential and certain dietary patterns are associated with polycystic ovary syndrome risk in China: A case-control study. Nutr Res 100:1–18. https://doi.org/10.1016/j.nutres.2021.12.006
Shang Y, Zhou H, Hu M, Feng H (2020) Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome. J Clin Endocrinol Metab 105: dgaa425. doi: https://doi.org/10.1210/clinem/dgaa425.
Norman AW, Okamura WH, Bishop JE, Henry HL (2002) Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3. Mol Cell Endocrinol 197:1–13. https://doi.org/10.1016/s0303-7207(02)00273-3
Maestro B, Dávila N, Carranza MC (2003) Calle C (2003) Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84:223–230. https://doi.org/10.1016/s0960-0760(03)00032-3
Maestro B, Molero S, Bajo S, Dávila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct 20:227–232. https://doi.org/10.1002/cbf.951
Contreras-Bolívar V, García-Fontana B, García-Fontana C, Muñoz-Torres M (2021) Mechanisms involved in the relationship between vitamin d and insulin resistance: impact on clinical practice. Nutrients 13:3491. https://doi.org/10.3390/nu13103491
Milner RD, Hales CN (1967) The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 3:47–49. https://doi.org/10.1007/BF01269910
Leung PS (2016) The potential protective action of vitamin d in hepatic insulin resistance and pancreatic islet dysfunction in type 2 diabetes mellitus. Nutrients 8:147. https://doi.org/10.3390/nu8030147
Kjalarsdottir L, Tersey SA, Vishwanath M, Chuang JC, Posner BA, Mirmira RG, Repa JJ (2019) 1,25-Dihydroxyvitamin D3 enhances glucose-stimulated insulin secretion in mouse and human islets: a role for transcriptional regulation of voltage-gated calcium channels by the vitamin D receptor. J Steroid Biochem Mol Biol 185:17–26. https://doi.org/10.1016/j.jsbmb.2018.07.004
Wimalawansa SJ (2019) Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology (Basel) 8:30. https://doi.org/10.3390/biology8020030
Morgante G, Darino I, Spanò A, Luisi S, Luddi A, Piomboni P, Governini L, De Leo V (2022) PCOS physiopathology and vitamin D deficiency: biological insights and perspectives for treatment. J Clin Med 11:4509. https://doi.org/10.3390/jcm11154509
Wei ZL, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy, et al (2018) Vitamin D switches BAF complexes to protect β cells. Cell. https://doi.org/10.1016/j.cell.201
Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka A, Papavassiliou AG, Panidis D (2008) Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 69:634–641. https://doi.org/10.1111/j.1365-2265.2008.03247.x
Garg D, Grazi R, Lambert-Messerlian GM, Merhi Z (2017) Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS. J Assist Reprod Genet 34:1507–1513. https://doi.org/10.1007/s10815-017-1011-6
Merhi Z, Buyuk E, Cipolla MJ (2018) Advanced glycation end products alter steroidogenic gene expression by granulosa cells: an effect partially reversible by vitamin D. Mol Hum Reprod 24:318–326. https://doi.org/10.1093/molehr/gay014
Bianchi L, Gagliardi A, Landi C, Focarelli R, De Leo V, Luddi A, Bini L, Piomboni P (2016) Protein pathways working in human follicular fluid: the future for tailored IVF? Expert Rev Mol Med 18:e9. https://doi.org/10.1017/erm.2016.4
Irani M, Merhi Z (2014) Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertil Steril 102:460–468. https://doi.org/10.1016/j.fertnstert.2014.04.046
Masjedi F, Keshtgar S, Zal F, Talaei-Khozani T, Sameti S, Fallahi S, Kazeroni M (2020) Effects of vitamin D on steroidogenesis, reactive oxygen species production, and enzymatic antioxidant defense in human granulosa cells of normal and polycystic ovaries. J Steroid Biochem Mol Biol 197:105521. https://doi.org/10.1016/j.jsbmb.2019.105521
Usluogullari B, Duvan C, Usluogullari C (2015) Use of aromatase inhibitors in practice of gynecology. J Ovarian Res 8:4. https://doi.org/10.1186/s13048-015-0131-9
Echchgadda I, Song CS, Roy AK, Chatterjee B (2004) Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 65:720–729. https://doi.org/10.1124/mol.65.3.720
Funding
The authors declare that no funds, grants, or other support was received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
RS: conceptualization, writing—original draft preparation, manuscript supervision, data collection. MA: manuscript review and editing, methodology, data analysis, supervision. DV: data analysis, methodology, writing—original draft preparation. AM: data analysis, methodology, writing—original draft preparation. OD: formal analysis, data curation. GMB: formal analysis, data curation. AM: formal analysis, data curation. AT: conceptualization, manuscript review and editing, manuscript supervision, data collection.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethics approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sparic, R., Andjic, M., Vergara, D. et al. PCOS and vitamin D: a clinical appraisal. Arch Gynecol Obstet 309, 907–915 (2024). https://doi.org/10.1007/s00404-023-07227-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-023-07227-x